Clinical trial Recruiting at 1 site Interventional Ages 18 to 30

Non-invasive cranial electrical stimulation to reduce mealtime anxiety in adults with eating disorders

Official title: Investigating Non-invasive Cranial Electrotherapy Stimulation for Acute Anxiety in Inpatients With Eating Disorders

Run by Rogers Behavioral Health · NCT07017322 · Data updated 2026-11-12

This trial will try using the Alpha‑Stim AID cranial electrical stimulation device to see if it lowers pre-meal anxiety in adults aged 18–30 who are hospitalized for eating disorders.

More Anxiety trials

Quick facts

Study typeInterventional
Ages18 Years to 30 Years
SexAll
Enrollment30 (estimated)
SponsorRogers Behavioral Health
Academic / other
Locations1 site (Oconomowoc, Wisconsin)
StatusRecruiting
StartedJune 3, 2025
Main results expectedNovember 1, 2027
Study endsNovember 1, 2027
Registry record updatedAugust 12, 2026
Trial IDNCT07017322 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18–30 admitted to the Rogers Behavioral Health Oconomowoc inpatient eating disorder program with a DSM‑5 eating disorder who show visible mealtime anxiety, low meal compliance (≤75%), or compensatory behaviors around meals.

Probably not a fit

Patients with metal implants, implanted devices, or on medications that lower seizure threshold, those outside the 18–30 age range, or patients without clinically significant mealtime anxiety are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study tests a protocol using the Alpha‑Stim AID cranial electrotherapy stimulation device delivered over a three‑session protocol to manage acute pre‑meal anxiety in inpatient eating disorder care. Researchers will track recruitment and retention, reasons for dropout, device side effects, missing patient‑reported data, and staff and patient acceptability. Secondary measures include pre‑meal anxiety on a 0–10 visual analogue scale, eating‑disorder symptom scores using the Eating Disorder‑15, and clinical impairment from disordered eating across the inpatient admission. The study is limited to adult inpatients at a single Rogers Behavioral Health site and excludes people with metal implants or certain medications that lower seizure threshold.

Why it matters

Potential benefit: If successful, this approach could offer a non‑drug option to reduce pre‑meal anxiety and help patients engage more effectively with inpatient eating disorder treatment.

How similar studies have gone: Cranial electrotherapy stimulation and Alpha‑Stim devices have shown small positive effects on anxiety in prior small trials, but using CES specifically for inpatient mealtime anxiety in eating disorders is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age 18-30 years old at the time of enrollment
2. Enrolled in Rogers Behavioral Health Eating Disorder Recovery Program Inpatient Unit at the Oconomowoc, WI clinic location
3. Have a primary diagnosis of any DSM-5 eating disorder (anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, other specified feeding or eating disorder)
4. Ability to communicate effectively using written and spoken English
5. Participant is eligible for mealtime anxiety support based on:

   * ≤ 75% meal plan compliance
   * Visible anxiety/distress during program meals
   * Engagement in compensatory behaviors or self-harm before, during, or after meals, or medical staff judge patient to be at risk of same

Exclusion Criteria:

1. Metal in the body of any kind (e.g., braces, pacemakers, metal plates or screws, intracranial electrodes, implanted devices/defibrillators, prostheses)
2. Currently taking medication that reduces seizure threshold (e.g., clomipramine)
3. Cranial pathologies (e.g., holes, plates)
4. History of seizure or black-out concussion
5. Pregnancy
6. Risk of suicide/self-harm by self-strangulation with cranial electrotherapy stimulation (CES) device judged by study medical staff
7. Participant calibrates to a stimulation level below 200 microampere (μA)

Where it's running

  • Rogers Behavioral Health
    Oconomowoc, Wisconsin, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.